Clinical trial
Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung…
NCT00004924 · Yale University, Other · Completed
Key facts
| NCT number | NCT00004924 |
|---|---|
| Title | Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer |
| Official title | Phase II Trial of Irinotecan Plus Paclitaxel in Patients With Advanced Nonsmall Cell Lung Cancer |
| Lead sponsor | Yale University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride, paclitaxel |
| Enrollment | 28 |
| Start date | Mar 1, 1999 |
| Completion | Feb 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 25, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: